Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
16.08
-1.02
(-5.95%)
At close: March 5 at 4:00:00 PM EST
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 4.77M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| HELTZEN MICHAEL Chief Executive Officer | Purchase at price 10.72 - 10.78 per share. | Direct | 20,345 | Jan 17, 2025 |
| HELTZEN MICHAEL Chief Executive Officer | Purchase at price 11.10 per share. | Direct | 22,022 | Nov 15, 2024 |
| MDB CAPITAL HOLDINGS, LLC Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security at price 6.40 per share. | Direct | 785,005 | Nov 8, 2024 |
| OPGENORTH PAUL HIDEO Officer | Conversion of Exercise of derivative security at price 6.40 per share. | Direct | 15,002 | Nov 8, 2024 |
Related Tickers
CUE Cue Biopharma, Inc.
1.1200
-4.27%
ASCLF Ascletis Pharma Inc.
0.8388
0.00%
PLRZ Polyrizon Ltd.
0.7704
+7.10%
CRTX.L CRISM Therapeutics Corporation
6.30
-3.08%
INTS Intensity Therapeutics, Inc.
2.3200
+4.98%
MAZE Maze Therapeutics, Inc.
11.87
+0.25%
IBO Impact BioMedical Inc.
1.1801
-18.05%
CTNM Contineum Therapeutics, Inc.
6.10
-2.40%
CHRO Channel Therapeutics Corporation
2.1600
-5.26%
UPB Upstream Bio, Inc.
8.47
+1.56%